Highlights and Quick Summary
- Total current liabilities for the quarter ending December 31, 2022 was $2.49 Million (a -17.34% decrease compared to previous quarter)
- Year-over-year quarterly Total current liabilities increased by 30.38%
- Annual Total current liabilities for 2022 was $2.53 Million (a 0.0% decrease from previous year)
- Annual Total current liabilities for 2022 was $2.53 Million (a 84.95% increase from previous year)
- Annual Total current liabilities for 2021 was $1.37 Million (a 0.0% decrease from previous year)
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Total current liabilities of Benitec Biopharma Limited
Most recent Total current liabilitiesof BNTC including historical data for past 10 years.Interactive Chart of Total current liabilities of Benitec Biopharma Limited
Benitec Biopharma Limited Total current liabilities for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $2.49 | $3.01 | $2.53 | $1.91 | $2.53 |
| 2021 | $2.48 | $1.6 | $1.37 | $2.44 | $1.37 |
| 2020 | $0.78 | $1.02 | $1.14 | $0.98 | $1.14 |
| 2019 | – | – | – | $0.74 | $2.64 |
| 2018 | – | – | – | – | $1.97 |
| 2017 | – | – | – | $1.34 | $0.85 |
| 2016 | – | $0.71 | $0.75 | $1.59 | $0.75 |
| 2015 | – | – | $0.72 | $1.37 | $1.37 |
| 2014 | – | – | $0.61 | $0.87 | $0.88 |
| 2013 | $1.14 | – | – | – | $1.14 |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology